TABLE 3.

w_T-Weighted Equivalent Organ Doses, Absorbed Doses, and LAR Values for Two 32-kg Pediatric Patients for ^99mTc-DMSA Renal Imaging Studies

	Short, stout (fifth bin 90th percentile, 125-cm height)				Tall, thin (seventh bin 10th percentile; 147-cm height)
			LAR*				LAR†
Target organ	wT H(rT)/A0 (mSv/MBq)	D(rT)/A0 (mGy/MBq)	10-y-old girl	Sex- and age-averaged	wT H(rT)/A0 (mSv/MBq)	D(rT)/A0 (mGy/MBq)	10-y-old girl	Sex- and age-averaged
Colon	7.81E–04	6.51E–03	0.6	0.5	4.94E–04	4.12E–03	0.2	0.2
Lungs	1.86E–03	1.55E–02	4.6	2.2	1.45E–03	1.21E–02	1.8	0.9
Stomach wall	2.16E–04	1.80E–03	0.1	0.0	1.52E–04	1.27E–03	0.0	0.0
Ovaries	3.79E–06	4.74E–05	0.0	0.0	3.74E–06	4.68E–05	0.0	0.0
Urinary bladder wall	2.57E–05	6.43E–04	0.1	0.0	2.16E–05	5.40E–04	0.0	0.0
Esophagus	9.22E–06	2.31E–04	–	–	5.40E–06	1.35E–04	–	–
Liver	2.97E–03	7.43E–02	0.9	0.9	2.16E–03	5.40E–02	0.3	0.3
Brain	6.53E–06	6.53E–04	–	–	1.59E–05	1.59E–03	–	–
Salivary glands	3.85E–07	3.85E–05	–	–	1.10E–06	1.10E–04	–	–
Skin	1.28E–04	1.28E–02	–	–	9.97E–05	9.97E–03	–	–
Remainder	7.57E–03	6.31E–02	–	–	4.96E–03	4.13E–02	–	–
Red bone marrow	5.26E–04	4.38E–03	0.2	0.2	4.09E–04	3.41E–03	0.1	0.1
Endosteum	9.22E–05	9.22E–03	–	–	7.18E–05	7.18E–03	–	–
Effective dose	1.42E–02				9.84E–03

^*No. of excess cancer incidence cases for population of 100,000 receiving AA of 1.85 MBq/kg (=59.2 MBq).

^†No. of excess cancer incidence cases for a population of 100,000 receiving AA of 0.93 MBq/kg (=29.6 MBq)